Chimeric peptidomimetic antibiotics against Gram-negative bacteria.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
12 2019
Historique:
received: 08 08 2018
accepted: 13 08 2019
pubmed: 28 10 2019
medline: 28 4 2020
entrez: 25 10 2019
Statut: ppublish

Résumé

There is an urgent need for new antibiotics against Gram-negative pathogens that are resistant to carbapenem and third-generation cephalosporins, against which antibiotics of last resort have lost most of their efficacy. Here we describe a class of synthetic antibiotics inspired by scaffolds derived from natural products. These chimeric antibiotics contain a β-hairpin peptide macrocycle linked to the macrocycle found in the polymyxin and colistin family of natural products. They are bactericidal and have a mechanism of action that involves binding to both lipopolysaccharide and the main component (BamA) of the β-barrel folding complex (BAM) that is required for the folding and insertion of β-barrel proteins into the outer membrane of Gram-negative bacteria. Extensively optimized derivatives show potent activity against multidrug-resistant pathogens, including all of the Gram-negative members of the ESKAPE pathogens

Identifiants

pubmed: 31645764
doi: 10.1038/s41586-019-1665-6
pii: 10.1038/s41586-019-1665-6
doi:

Substances chimiques

Anti-Bacterial Agents 0
Bacterial Outer Membrane Proteins 0
BamA protein, E coli 0
Biological Products 0
Escherichia coli Proteins 0
Lipopolysaccharides 0
Macrocyclic Compounds 0
Peptidomimetics 0
Photoaffinity Labels 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

452-458

Subventions

Organisme : Wellcome Trust
ID : 202728/Z/16/Z
Pays : United Kingdom

Commentaires et corrections

Type : ErratumIn
Type : CommentIn

Références

WHO. Global Priority List of Antibiotic-resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics (World Health Organization, Geneva, 2017).
Boucher, H. W. et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin. Infect. Dis. 48, 1–12 (2009).
doi: 10.1086/595011
O’Neill, J. Project Syndicate – A Call to Antimicrobial Arms  https://www.project-syndicate.org/commentary/antibiotics-resistance-economic-costs-by-jim-o-neill-2015-02 (2015).
Paterson, D. L. & Harris, P. N. A. Colistin resistance: a major breach in our last line of defence. Lancet Infect. Dis. 16, 132–133 (2016).
doi: 10.1016/S1473-3099(15)00463-6
Henderson, J. C. et al. The power of asymmetry: architecture and assembly of the Gram-negative outer membrane bilayer. Annu. Rev. Microbiol. 70, 255–278 (2016).
doi: 10.1146/annurev-micro-102215-095308
Konovalova, A., Kahne, D. E. & Silhavy, T. J. Outer membrane biogenesis. Annu. Rev. Microbiol. 71, 539–556 (2017).
doi: 10.1146/annurev-micro-090816-093754
Srinivas, N. et al. Peptidomimetic antibiotics target outer-membrane biogenesis in Pseudomonas aeruginosa. Science 327, 1010–1013 (2010).
doi: 10.1126/science.1182749
Werneburg, M. et al. Inhibition of lipopolysaccharide transport to the outer membrane in Pseudomonas aeruginosa by peptidomimetic antibiotics. ChemBioChem 13, 1767–1775 (2012).
doi: 10.1002/cbic.201200276
Noinaj, N., Rollauer, S. E. & Buchanan, S. K. The β-barrel membrane protein insertase machinery from Gram-negative bacteria. Curr. Opin. Struct. Biol. 31, 35–42 (2015).
doi: 10.1016/j.sbi.2015.02.012
Storm, D. R., Rosenthal, K. S. & Swanson, P. E. Polymyxin and related peptide antibiotics. Annu. Rev. Biochem. 46, 723–763 (1977).
doi: 10.1146/annurev.bi.46.070177.003451
Mares, J., Kumaran, S., Gobbo, M. & Zerbe, O. Interactions of lipopolysaccharide and polymyxin studied by NMR spectroscopy. J. Biol. Chem. 284, 11498–11506 (2009).
doi: 10.1074/jbc.M806587200
Roberts, K. D. et al. Antimicrobial activity and toxicity of the major lipopeptide components of polymyxin B and colistin: last-line antibiotics against multidrug-resistant Gram-negative bacteria. ACS Infect. Dis. 1, 568–575 (2015).
doi: 10.1021/acsinfecdis.5b00085
Baron, S., Hadjadj, L., Rolain, J.-M. & Olaitan, A. O. Molecular mechanisms of polymyxin resistance: knowns and unknowns. Int. J. Antimicrob. Agents 48, 583–591 (2016).
doi: 10.1016/j.ijantimicag.2016.06.023
Olaitan, A. O., Morand, S. & Rolain, J.-M. Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria. Front. Microbiol. 5, 643 (2014).
doi: 10.3389/fmicb.2014.00643
Raetz, C. R., Reynolds, C. M., Trent, M. S. & Bishop, R. E. Lipid A modification systems in Gram-negative bacteria. Annu. Rev. Biochem. 76, 295–329 (2007).
doi: 10.1146/annurev.biochem.76.010307.145803
Groisman, E. A. The pleiotropic two-component regulatory system PhoP–PhoQ. J. Bacteriol. 183, 1835–1842 (2001).
doi: 10.1128/JB.183.6.1835-1842.2001
McPhee, J. B., Lewenza, S. & Hancock, R. E. Cationic antimicrobial peptides activate a two-component regulatory system, PmrA–PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa. Mol. Microbiol. 50, 205–217 (2003).
doi: 10.1046/j.1365-2958.2003.03673.x
Okuda, S., Sherman, D. J., Silhavy, T. J., Ruiz, N. & Kahne, D. Lipopolysaccharide transport and assembly at the outer membrane: the PEZ model. Nat. Rev. Microbiol. 14, 337–345 (2016).
doi: 10.1038/nrmicro.2016.25
Hartmann, J.-B., Zahn, M., Burmann, I. M., Bibow, S. & Hiller, S. Sequence-specific solution NMR assignments of the β-barrel insertase BamA to monitor its conformational ensemble at the atomic level. J. Am. Chem. Soc. 140, 11252–11260 (2018).
doi: 10.1021/jacs.8b03220
Mahoney, T. F., Ricci, D. P. & Silhavy, T. J. Classifying β-barrel assembly substrates by manipulating essential Bam complex members. J. Bacteriol. 198, 1984–1992 (2016).
doi: 10.1128/JB.00263-16
Lee, J. et al. Characterization of a stalled complex on the β-barrel assembly machine. Proc. Natl Acad. Sci. USA 113, 8717–8722 (2016).
doi: 10.1073/pnas.1604100113
Gunasinghe, S. D. et al. The WD40 protein BamB mediates coupling of BAM complexes into assembly precincts in the bacterial outer membrane. Cell Rep. 23, 2782–2794 (2018).
doi: 10.1016/j.celrep.2018.04.093
Mitchell, A. M. & Silhavy, T. J. Envelope stress responses: balancing damage repair and toxicity. Nat. Rev. Microbiol. 17, 417–428 (2019).
doi: 10.1038/s41579-019-0199-0
Storek, K. M. et al. Monoclonal antibody targeting the β-barrel assembly machine of Escherichia coli is bactericidal. Proc. Natl Acad. Sci. USA 115, 3692–3697 (2018).
doi: 10.1073/pnas.1800043115
Browning, D. F. et al. Mutational and topological analysis of the Escherichia coli BamA protein. PLoS ONE 8, e84512 (2013).
doi: 10.1371/journal.pone.0084512
Lee, J. et al. Substrate binding to BamD triggers a conformational change in BamA to control membrane insertion. Proc. Natl Acad. Sci. USA 115, 2359–2364 (2018).
doi: 10.1073/pnas.1711727115
Rigel, N. W., Ricci, D. P. & Silhavy, T. J. Conformation-specific labeling of BamA and suppressor analysis suggest a cyclic mechanism for β-barrel assembly in Escherichia coli. Proc. Natl Acad. Sci. USA 110, 5151–5156 (2013).
doi: 10.1073/pnas.1302662110
Dixon, R. A. & Chopra, I. Polymyxin B and polymyxin B nonapeptide alter cytoplasmic membrane permeability in Escherichia coli. J. Antimicrob. Chemother. 18, 557–563 (1986).
doi: 10.1093/jac/18.5.557
Moffatt, J. H. et al. Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production. Antimicrob. Agents Chemother. 54, 4971–4977 (2010).
doi: 10.1128/AAC.00834-10
Choi, M. et al. MSstats: an R package for statistical analysis of quantitative mass spectrometry-based proteomic experiments. Bioinformatics 30, 2524–2526 (2014).
doi: 10.1093/bioinformatics/btu305
Carlson, M. UniProt.ws: R interface to UniProt web services. R package version 2.14.0. https://bioconductor.org/packages/release/bioc/html/UniProt.ws.html (2018)

Auteurs

Anatol Luther (A)

Polyphor AG, Allschwil, Switzerland.

Matthias Urfer (M)

Chemistry Department, University of Zurich, Zurich, Switzerland.

Michael Zahn (M)

Biozentrum, University of Basel, Basel, Switzerland.

Maik Müller (M)

Institute of Molecular Systems Biology & Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland.

Shuang-Yan Wang (SY)

Chemistry Department, University of Zurich, Zurich, Switzerland.

Milon Mondal (M)

Chemistry Department, University of Zurich, Zurich, Switzerland.

Alessandra Vitale (A)

Department of Plant and Microbial Biology, University of Zurich, Zurich, Switzerland.

Jean-Baptiste Hartmann (JB)

Biozentrum, University of Basel, Basel, Switzerland.

Timothy Sharpe (T)

Biozentrum, University of Basel, Basel, Switzerland.

Fabio Lo Monte (FL)

Chemistry Department, University of Zurich, Zurich, Switzerland.

Harsha Kocherla (H)

Chemistry Department, University of Zurich, Zurich, Switzerland.

Elizabeth Cline (E)

Chemistry Department, University of Zurich, Zurich, Switzerland.

Gabriella Pessi (G)

Department of Plant and Microbial Biology, University of Zurich, Zurich, Switzerland.

Parthasarathi Rath (P)

Biozentrum, University of Basel, Basel, Switzerland.

Seyed Majed Modaresi (SM)

Biozentrum, University of Basel, Basel, Switzerland.

Petra Chiquet (P)

Polyphor AG, Allschwil, Switzerland.

Sarah Stiegeler (S)

Polyphor AG, Allschwil, Switzerland.

Carolin Verbree (C)

Polyphor AG, Allschwil, Switzerland.

Tobias Remus (T)

Polyphor AG, Allschwil, Switzerland.

Michel Schmitt (M)

Polyphor AG, Allschwil, Switzerland.

Caroline Kolopp (C)

Polyphor AG, Allschwil, Switzerland.

Marie-Anne Westwood (MA)

Polyphor AG, Allschwil, Switzerland.

Nicolas Desjonquères (N)

Polyphor AG, Allschwil, Switzerland.

Emile Brabet (E)

Polyphor AG, Allschwil, Switzerland.

Sophie Hell (S)

Polyphor AG, Allschwil, Switzerland.

Karen LePoupon (K)

Polyphor AG, Allschwil, Switzerland.

Annie Vermeulen (A)

Polyphor AG, Allschwil, Switzerland.

Régis Jaisson (R)

Polyphor AG, Allschwil, Switzerland.

Virginie Rithié (V)

Polyphor AG, Allschwil, Switzerland.

Grégory Upert (G)

Polyphor AG, Allschwil, Switzerland.

Alexander Lederer (A)

Polyphor AG, Allschwil, Switzerland.

Peter Zbinden (P)

Polyphor AG, Allschwil, Switzerland.

Achim Wach (A)

Polyphor AG, Allschwil, Switzerland.

Kerstin Moehle (K)

Chemistry Department, University of Zurich, Zurich, Switzerland.

Katja Zerbe (K)

Chemistry Department, University of Zurich, Zurich, Switzerland.

Hans H Locher (HH)

Polyphor AG, Allschwil, Switzerland.

Francesca Bernardini (F)

Polyphor AG, Allschwil, Switzerland.

Glenn E Dale (GE)

Polyphor AG, Allschwil, Switzerland.

Leo Eberl (L)

Department of Plant and Microbial Biology, University of Zurich, Zurich, Switzerland.

Bernd Wollscheid (B)

Institute of Molecular Systems Biology & Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland.

Sebastian Hiller (S)

Biozentrum, University of Basel, Basel, Switzerland.

John A Robinson (JA)

Chemistry Department, University of Zurich, Zurich, Switzerland. john.robinson@chem.uzh.ch.

Daniel Obrecht (D)

Polyphor AG, Allschwil, Switzerland. daniel.obrecht@polyphor.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH